119 related articles for article (PubMed ID: 20636185)
1. Antitumor conjugates with polyamine vectors and their molecular mechanisms.
Xie S; Wang J; Zhang Y; Wang C
Expert Opin Drug Deliv; 2010 Sep; 7(9):1049-61. PubMed ID: 20636185
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antitumor activity of bile acid-polyamine-nucleoside conjugates.
Wu D; Ji S; Wu Y; Ju Y; Zhao Y
Bioorg Med Chem Lett; 2007 Jun; 17(11):2983-6. PubMed ID: 17416522
[TBL] [Abstract][Full Text] [Related]
3. Polyamine-vectored iron chelators: the role of charge.
Bergeron RJ; Bharti N; Wiegand J; McManis JS; Yao H; Prokai L
J Med Chem; 2005 Jun; 48(12):4120-37. PubMed ID: 15943485
[TBL] [Abstract][Full Text] [Related]
4. Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates.
Wang C; Delcros JG; Biggerstaff J; Phanstiel O
J Med Chem; 2003 Jun; 46(13):2672-82. PubMed ID: 12801231
[TBL] [Abstract][Full Text] [Related]
5. The polyamine transport system as a target for anticancer drug development.
Palmer AJ; Wallace HM
Amino Acids; 2010 Feb; 38(2):415-22. PubMed ID: 19956998
[TBL] [Abstract][Full Text] [Related]
6. Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters.
Wang C; Delcros JG; Cannon L; Konate F; Carias H; Biggerstaff J; Gardner RA; Phanstiel IV O
J Med Chem; 2003 Nov; 46(24):5129-38. PubMed ID: 14613316
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
Greco F; Vicent MJ
Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
[TBL] [Abstract][Full Text] [Related]
8. Development of polyamine analogs as cancer therapeutic agents.
Thomas T; Balabhadrapathruni S; Gallo MA; Thomas TJ
Oncol Res; 2002; 13(3):123-35. PubMed ID: 12555742
[TBL] [Abstract][Full Text] [Related]
9. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
10. Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers: chemical structure, morphology, and gene transfer activity.
Dewa T; Asai T; Tsunoda Y; Kato K; Baba D; Uchida M; Sumino A; Niwata K; Umemoto T; Iida K; Oku N; Nango M
Bioconjug Chem; 2010 May; 21(5):844-52. PubMed ID: 20377241
[TBL] [Abstract][Full Text] [Related]
11. N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters.
Gardner RA; Delcros JG; Konate F; Breitbeil F; Martin B; Sigman M; Huang M; Phanstiel O
J Med Chem; 2004 Nov; 47(24):6055-69. PubMed ID: 15537360
[TBL] [Abstract][Full Text] [Related]
12. The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs.
Wang J; Luo T; Li S; Zhao J
Expert Opin Drug Deliv; 2012 Jan; 9(1):1-7. PubMed ID: 22171694
[TBL] [Abstract][Full Text] [Related]
13. A novel polymeric spermine conjugate inhibits polyamine transport in pulmonary artery smooth muscle cells.
Aziz SM; Gosland MP; Crooks PA; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1995 Jul; 274(1):181-6. PubMed ID: 7616397
[TBL] [Abstract][Full Text] [Related]
14. Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines.
Delcros JG; Tomasi S; Duhieu S; Foucault M; Martin B; Le Roch M; Eifler-Lima V; Renault J; Uriac P
J Med Chem; 2006 Jan; 49(1):232-45. PubMed ID: 16392808
[TBL] [Abstract][Full Text] [Related]
15. Tumour-targeted drug and gene delivery: principles and concepts.
Cassidy J; Schätzlein AG
Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
[TBL] [Abstract][Full Text] [Related]
16. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
Marcucci F; Lefoulon F
Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
[TBL] [Abstract][Full Text] [Related]
17. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity investigations of polyamine-anthracene conjugates and their uptake via the polyamine transporter.
Phanstiel O; Kaur N; Delcros JG
Amino Acids; 2007 Aug; 33(2):305-13. PubMed ID: 17410331
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
20. 'Smart' delivery systems for biomolecular therapeutics.
Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
